NCT00294996_1A: NCT00294996, figure 1A

NCT00294996_1AR Documentation

NCT00294996, figure 1A

Description

Kaplan-Meier digitized data from NCT00294996, figure 1A (PMID 24401928). A reported sample size of 181 for a primary endpoint of PFS in breast cancer.

Usage

NCT00294996_1A

Format

A data frame of 363 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (mpt, pt)

Source

Baselga J, Manikhas A, Cortés J, et al. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol 2014; 25: 592–8.

Examples

summary(NCT00294996_1A)

kmplot(NCT00294996_1A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.